Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Portfolio Pulse from Benzinga Insights
Abbott Laboratories (NYSE:ABT) has received mixed analyst ratings over the past three months, with a majority being bullish. Analysts have set a 12-month price target range between $120 and $143, with an average of $127.2. The company's financial performance shows strong net margins and ROE, but revenue growth lags behind industry peers.

August 22, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Abbott Laboratories has received mixed analyst ratings, with a majority being bullish. The 12-month price target average is $127.2, slightly down from previous estimates. The company's financials show strong net margins and ROE, but revenue growth is below industry peers.
The mixed analyst ratings suggest a neutral short-term impact on Abbott's stock price. While the majority of analysts are bullish, the slight decrease in the average price target and the company's lagging revenue growth compared to peers balance out the positive sentiment. The strong financial metrics like net margins and ROE provide a solid foundation, but the market may already have priced in these factors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100